Chen S, Lu D, Zhang M, Che J, Yin Z, Zhang S, Zhang W, Bo X, Ding Y, Wang S
Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing, 100850, People's Republic of China.
Eur J Clin Microbiol Infect Dis. 2005 Aug;24(8):549-53. doi: 10.1007/s10096-005-1378-7.
The study presented here was conducted to evaluate the performance of a double-antigen sandwich ELISA to detect antibodies in human serum against the coronavirus associated with severe acute respiratory syndrome (SARS). A recombinant partial nucleocapsid protein of SARS-associated coronavirus was used as a serodiagnostic antigen in the ELISA. A total of 2892 clinical serum samples were tested with the ELISA kit, which positively identified 25 of 35 (71.4%) samples of patients with confirmed SARS infection, 286 of 407 (70%) samples of patients suspected of having SARS, 229 of 302 (75.8%) samples of convalescent SARS patients, and 0 of 544 samples obtained from healthcare workers; only 1 of 1604 clinical samples obtained from patients with other diseases demonstrated a weakly positive result. These results indicate that the double-antigen sandwich ELISA is an effective screening method for the serodiagnosis of SARS-associated coronavirus.
开展本研究是为了评估双抗原夹心酶联免疫吸附测定法(ELISA)检测人血清中针对严重急性呼吸综合征(SARS)相关冠状病毒抗体的性能。SARS相关冠状病毒的重组部分核衣壳蛋白用作ELISA中的血清诊断抗原。使用ELISA试剂盒检测了总共2892份临床血清样本,该试剂盒阳性鉴定出35例确诊SARS感染患者中的25例(71.4%)、407例疑似SARS患者中的286例(70%)、302例SARS康复患者中的229例(75.8%)以及544份医护人员样本中的0例;在1604份来自其他疾病患者的临床样本中,只有1例呈弱阳性结果。这些结果表明,双抗原夹心ELISA是SARS相关冠状病毒血清诊断的一种有效筛查方法。